Highland Capital Management (Texas)’s AstraZeneca AZN Stock Holding History

Highland Capital Management (Texas)’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	$619K	Buy	7,500 +2,500	+50%	+$196K	0.04%	239
2019 Q1	$404K	Buy	+5,000	New	+$394K	0.03%	257
2018 Q4	–	Sell	-15,000	Closed	-$1.19M	–	273
2018 Q3	$1.19M	Buy	15,000 +5,000	+50%	+$378K	0.07%	165
2018 Q2	$702K	Sell	10,000 -10,000	-50%	-$719K	0.04%	179
2018 Q1	$1.4M	Buy	+20,000	New	+$1.39M	0.08%	169
2017 Q1	–	Sell	-210,225	Closed	-$11.5M	–	288
2016 Q4	$11.5M	Sell	210,225 -213,475	-50%	-$12.1M	0.65%	53
2016 Q3	$27.8M	Buy	423,700 +403,700	+2,019%	+$26.4M	1.48%	27
2016 Q2	$1.21M	Sell	20,000 -113,180	-85%	-$6.57M	0.07%	179
2016 Q1	$7.5M	Buy	+133,180	New	+$8M	0.4%	85

Other funds holding AZN

Wellington Management Group

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Primecap Management

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fidelity Investments

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Jennison Associates

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Bank of America

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Capital International Investors

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Fisher Asset Management

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

T. Rowe Price Associates

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Arrowstreet Capital

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return